-+ 0.00%
-+ 0.00%
-+ 0.00%

Biopharmaceutical company TG Therapeutics (TGTX.US) shares plummeted, Q1 earnings fell short of expectations

Zhitongcaijing·05/05/2025 14:09:03
Listen to the news

The Zhitong Finance App learned that at the beginning of the US stock market on Monday, as of press release, the stock price of biopharmaceutical company TG Therapeutics (TGTX.US) plummeted by nearly 15%. According to the news, the financial report for the first quarter of 2025 released by TG Therapeutics showed that Q1 revenue was US$121 million, up 90.4% year-on-year, and US$3 million higher than analysts' expectations; GAAP earnings per share were US$0.03, which was $0.14 lower than analysts' expectations.